With Omicron: Negative Efficacy Like Never Before
With Omicron: Negative Efficacy Like Never Before
UKHSA Vaccine Efficacy Statistics: 2022, Week 1
Because of my reduced Christmas posting schedule, I missed the UKHSA Week 51 report, so I owe you, loyal readers, a few graphs.
First, let us cast our minds back to the Week 50 report. Here’s what case rates by vaccination status looked like then:
At the time, remember, we were preoccupied by the effect of booster doses in restoring positive efficacy for the 60+ crowd; meanwhile, younger age brackets were sliding ever deeper into negative territory. For context: Between 15 Nov. and 12 Dec., Omicron still accounted for no more than a minority of infections in the UK.
The week 51 numbers, where the four-week running average is shifted just one week later, look vastly different:
This must be a combination of pre-holiday testing and Omicron, which by 19 Dec. was surging towards 40% of all infections in Britain.
The latest data from the 2022 Week 1 report that dropped yesterday reveal an even more pronounced pattern, with negative efficacy returning to every age bracket over 18:
For what it’s worth, the UKHSA test negative-control investigation of vaccine effectiveness against symptomatic Omicron infection (where vaccination rates in PCR negatives are compared to vaccination rates in PCR positives) finds that vaccine effectiveness in the double-dosed does not fade below zero. Their latest analysis includes 169,888 Delta cases and 204,036 Omicron cases. Here’s two doses of AstraZeneca with either a BioNTech or a Moderna booster:
And two doses of BioNTech with a BioNTech or Moderna booster:
As the Health Security Agency loves to tell us, their numbers showing negative efficacy are unadjusted, and doubtless unreliable, because there’s no way of knowing the precise size of the unvaccinated population. Nevertheless, it seems clear by now that negative efficacy is real. It looks like the more you test regardless of symptoms, the more you find it. This would be why it emerges so strongly in pre-Christmas testing, when millions of perfectly healthy people got tested to know whether it was safe to see their elderly relatives. This would also be why the effect is missing from the UKHSA test negative-control numbers, which look only at people who sought out testing because of illness.
Now as is customary, the 60-day death numbers …
and the 60-day death rates:
UPDATE: See also T. Coddington (at I Numero) on the same report.
Not bad for a mRNA injection with an absolute risk reduction factor of 1%. What is happening is entirely predictable. The mRNA experimental injections do nothing other than scramble your immune system which is their main purpose anyway.
You are always gonna need another mRNA injection for eternity because they do not have any efficacy against any virus. Meanwhile, with each new injection your poor immune system is going to become even more degraded and thus any nasties lurking around might get a foothold.
Then comes the best part, if you are still breathing. You get to enter the modern stone-age medical system as a life long patient...good for the doctors and hospitals, good for the drug companies and not so good for you. Because you don't count anymore. You are just another body to be sucked dry of your dignity, health and wealth.
" It looks like the more you test regardless of symptoms, the more you find it."
Trump got boo'd off the stage for making this astute observation ~nearly 2 years ago.
Policies that drive notSick people to get tested while tests produce falsePositives is recipe for fiat casedemic (always has been, see Nancy's "test test test" propaganda early on, they knew the game)